Presidio Pharmaceuticals and Boehringer Ingelheim non-exclusively partnered to evaluate an all-oral regimen of the companies' HCV compounds in a Phase IIa trial

Presidio Pharmaceuticals Inc.

U.S. / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Boehringer Ingelheim GmbH

Germany / Private Biopharma

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced